Palo Alto-Based Group Gets Grant To Target Hepatitis C
The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $305,000 grant to Palo Alto-based StemCells to research and develop a potential cell-based therapy for liver disease resulting from hepatitis C infection.
- "StemCells Gets Grant To Fight Hepatitis C" (Silicon Valley/San Jose Business Journal, 10/2).